ArticleBioengineered2022

Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway.

Meng-Hui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.